» Articles » PMID: 29606817

Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 And/or Photodynamic Therapy

Overview
Journal Ann Dermatol
Specialty Dermatology
Date 2018 Apr 3
PMID 29606817
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Folliculotropic mycosis fungoides (FMF) is a variant of mycosis fungoides (MF) that is characterized clinically by variable types of skin eruptions, including plaques, acneiform lesions, and alopecic patches. Histopathologically, FMF is characterized by folliculotropic infiltrates.

Objective: This study was conducted to scrutinize the clinical and histopathologic features of FMF in Koreans and the responses to phototherapy.

Methods: Twenty Koreans diagnosed with MF who had histopathologic evidence of folliculotropism were enrolled.

Results: Eighteen patients had head-and-neck-region infiltration, while five had solitary lesion. In all patients, the atypical lymphocytic infiltrate had a perifollicular distribution. Twelve patients were treated with ultraviolet A (UVA)-1. Eleven of these 12 patients with early-stage FMF experienced >80% improvement (8: complete remission; 3: partial remission). Four patients, including 2 who relapsed after UVA-1, were treated with photodynamic therapy (PDT), reaching complete remission after PDT.

Conclusion: As FMF has variable clinical presentations, skin biopsy is required to confirm the diagnosis. And both UVA-1 and methyl aminolevulinate-PDT are clinically effective in treatment of early-stage FMF.

References
1.
van Doorn R, Scheffer E, Willemze R . Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol. 2002; 138(2):191-8. DOI: 10.1001/archderm.138.2.191. View

2.
Gerami P, Guitart J . The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides. Am J Surg Pathol. 2007; 31(9):1430-8. DOI: 10.1097/PAS.0b013e3180439bdc. View

3.
Olek-Hrab K, Silny W, Danczak-Pazdrowska A, Osmola-Mankowska A, Sadowska P, Polanska A . Ultraviolet A1 phototherapy for mycosis fungoides. Clin Exp Dermatol. 2012; 38(2):126-30. DOI: 10.1111/ced.12001. View

4.
Jang M, Kang D, Han S, Park J, Kim S, Suh K . CD25+ folliculotropic Sézary syndrome with CD30+ large cell transformation. Australas J Dermatol. 2012; 55(1):e4-8. DOI: 10.1111/ajd.12000. View

5.
Debu A, Bessis D, Girard C, Du Thanh A, Guillot B, Dereure O . Photodynamic therapy with methyl aminolaevulinate for cervical and/or facial lesions of folliculotropic mycosis fungoides: interest and limits. Br J Dermatol. 2012; 168(4):896-8. DOI: 10.1111/bjd.12064. View